DC-T cell axis is an effective target for treating non-small cell lung cancer

Shuangcui Wang; Guan Zhang; qian cui; Yanjie  Yang; Dong Wang; Aqing  Liu; Ying Xia; Wentao  Li; Yunhe  Liu; Jianchun  Yu

doi:10.22541/au.170663758.81686606/v1

loading page

DC-T cell axis is an effective target for treating non-small cell lung cancer

Shuangcui Wang,
Guan Zhang,
qian cui,
Yanjie Yang,
Dong Wang,
Aqing Liu,
Ying Xia,
Wentao Li,
Yunhe Liu,
Jianchun Yu

Abstract

The DC-T cell axis is a bridge connecting innate immunity and adaptive immunity. The initial immune response against tumors is mainly induced by mature antigen-presenting dendritic cells (DC). Enhancing the crosstalk between DC and T cells could improve the immune response to non-small cell lung cancer. This article reviews the interaction between DC-T cells in the treatment of non-small cell lung cancer and how this interaction impacts the treatment outcome.

13 Apr 2023Submitted to Immunity, Inflammation and Disease

Show details

Hide details

19 Apr 2023Submission Checks Completed

19 Apr 2023Assigned to Editor

19 Apr 2023Review(s) Completed, Editorial Evaluation Pending

25 Apr 2023Reviewer(s) Assigned

18 Oct 2023Editorial Decision: Revise Minor

30 Oct 20231st Revision Received

02 Nov 2023Assigned to Editor

02 Nov 2023Submission Checks Completed

02 Nov 2023Review(s) Completed, Editorial Evaluation Pending

02 Nov 2023Reviewer(s) Assigned

02 Nov 2023Editorial Decision: Revise Minor

06 Nov 20232nd Revision Received

06 Nov 2023Assigned to Editor

06 Nov 2023Submission Checks Completed

06 Nov 2023Review(s) Completed, Editorial Evaluation Pending

09 Nov 2023Reviewer(s) Assigned

09 Nov 2023Editorial Decision: Accept

Nov 2023Published in Immunity, Inflammation and Disease volume 11 issue 11. https://doi.org/10.1002/iid3.1099

Abstract

Peer review status:Published